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Objectives. This study investigated whether exercise-induced 
myocardial ischemia influences left ventricular remodeling after 
anterior myocardial infarction. 
Background. The effects of acute and recurrent ischemia on 
ventricnlar function are well established. However, to our knowl- 
edge the role of exertional ischemia in the remodeling response 
after infarction has not been investigated. 
Methods. Ninety-one patients with a first anterior Q wave 
myocardial infarction were studied at 5 weeks by rest echocardi- 
ography and exercise scintigraphy. The echocardiographic exam- 
ination was repeated 6 months later. On the basis of the presence 
and extent of reversible perfusion defects on exercise scintigraphy, 
patients were assigned to groups with no exertional ischemia 
(group 1, n = 20 [22%]), mild to moderate ischemia (group 2, n = 
45 [49%]) and severe xertional ischemia (group 3, n = 26 [29%]). 
Results. Initial left ventricular volumes were similar, and no 
differences were found among the three groups in the remodeling 
response over the 6-month period of the study. However, patients 
in groups 2 and 3 with an ejection fraction <40% showed 
significant (p < 0.01) ventricular enlargement over time, which 
was similar between the two groups (end-diastolic volume 
[mean -+ SD] from 74 -+ 13 to 80 -+ 17 ml/m 2 in group 2 and from 
72 -+ 11 to 81 -+ 19 ml/m 2 in group 3; regional dilation from 42 - 
16% to 52 -+ 22% in group 2 and from 38 -+ 18% to 46 -+ 27% in 
group 3). In contrast, ventricular dimensions did not change in 
group 1 patients with an ejection fraction <40% as well as in 
patients in all three groups with an ejection fraction >40%. 
Conclusions. Exercise-induced myocardial ischemia may con- 
tribute to progressive ventricular enlargement in patients with 
poor left ventricular function after a large anterior myocardial 
infarction. 
(JAm CoU Cardio11995;25:1539-46) 
It is well established that ventricular enlargement after myo- 
cardial infarction is not limited to the early phase but is a 
dynamic process, involving both the infarcted and noninfarcted 
regions, that leads to progressive late ventricular dilation and 
can profoundly affect both ventricular function and prognosis 
(1-12). Although ventricular enlargement is primarily related 
to the extent and location of the histologic damage, other 
interdependent factors may influence and modify the remod- 
eling process, including reperfusion, infarct healing, ventricu- 
lar wall stress, different loading conditions and medications 
(5-7,9,10,13-24). It has also been demonstrated (25-27) in 
patients who have undergone thrombolysis that the level of 
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blood flow after reperfusion, degree of residual coronary 
stenosis and occurrence of reocclusion are important determi- 
nants of the remodeling response after myocardial infarction. 
Recurrent ischemia due to residual stenosis of the infarct- 
related vessel or by disease in other coronary vessels may 
further contribute to unfavorable remodeling in some patients 
(28). However, although the effects of acute ischemia on both 
global and regional eft ventricular function are well estab- 
lished (28,29), to our knowledge no clinical studies are avail- 
able on the possible role of exertional ischemia in ventricular 
remodeling after myocardial infarction. 
Accordingly, this study was undertaken to investigate 
whether residual exercise-induced myocardial ischemia, de- 
tected soon after the acute episode, would influence the 
remodeling response after anterior myocardial infarction. 
Methods  
Study patients. We prospectively studied 96 consecutive 
male patients (mean [+SD] age 50 + 8 years) with recent 
anterior myocardial infarction who met the following inclusion 
criteria: 1) history of a recent (4 to 6 weeks previously) first Q 
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wave anterior myocardial infarction; 2) sinus rhythm and no 
atrioventricular o intraventricular conduction disturbances; 3)
no angina at rest; 4) New York Heart Association functional 
class I or II; and 5) echocardiographic images of adequate 
quality for quantitative analysis. The diagnosis of acute myo- 
cardial infarction was supported by a typical history of chest 
pain (>30 rain), evolutionary electrocardiographic (ECG) 
changes with new abnormal Q waves (->30 ms) in at least wo 
adjacent precordial leads and in leads I or aVL, or both, and a 
typical pattern of elevated serum myocardial enzyme levels. 
Exclusion criteria were 1) systemic diseases; 2) severe left 
ventricular dysfunction as detected by a rest ejection fraction 
<25%; 3) low threshold ischemia (-<50 W) or exertional 
angina uncontrolled by medical therapy; and 4) inability to 
participate in a prospective study for any logistic reason. 
Study protocol. Regional myocardial perfusion both at rest 
and at peak exercise was evaluated with sestamibi single- 
photon emission computed tomography. Left ventricular vol- 
umes and regional and global function were assessed at rest by 
two-dimensional echocardiography. All patients underwent 
both rest and exercise scintigraphy and rest echocardiography 
4 to 6 weeks after the acute episode (study 1); then the 
echocardiographic examination at rest was repeated 6 months 
later (study 2). Patients had to be in clinically stable condition 
during the interval between the two studies. Cardioactive drugs 
were discontinued at least 48 h before each evaluation. At 
study 1, rest sestamibi and echocardiography were performed 
on the same day, and exercise scintigraphy within 24 h. 
Coronary artery angiography was also performed uring the 
6-month period of the study. 
The study protocol had been approved by the local Science 
and Ethics Committee on Human Research. Informed consent 
was obtained from all patients. 
Sestamibi maging and analysis. Patients underwent rest 
and exercise scintigraphy, on average, at 5 (4 to 6) weeks after 
the acute episode (study 1). Rest and exercise scans were 
performed inrandom order using a 2-day imaging protocol. A 
multistage symptom-limited bicycle ergometric test was used. 
Incremental loads of 25 W were given every 3 rain. The ECG 
was monitored continuously from lead V 5 and recorded on 
paper from all leads every minute. Sphygmomanometric blood 
pressure was also measured every 3 min. The criteria for 
stopping the test have been previously reported (30). The 
tracer was injected intravenously atpeak exercise, and patients 
were then encouraged to continue xercising a further 60 to 
90 s. The method of sestamibi scan acquisition and processing 
has recently been described (31). Briefly, both the rest and 
exercise scintigraphic images were obtained within 90 to 
120 min after the tracer injection (25 mCi/70 kg). The camera 
head (Apex 40~Elscint) was rotated in a 180 °arc in a circular 
orbit from the 30 ° right anterior oblique angle to the 30 o left 
posterior angle. Data were collected in a 64 × 64 array with a 
pixel size of 4.5 ram. Particular care was taken to avoid major 
artifacts, such as patient motion during acquisition. 
Transaxial slices were reconstructed using a filtered back- 
projection algorithm with a modified Wienner filter. Short- and 
long-axis (horizontal and vertical) tomograms were recon- 
structed from the transaxial slices. All studies were processed 
by a single experienced operator (C.M.) who was unaware of 
the clinical and functional data. Slices in the short-axis view 
were reconstructed, and polar maps of the regional sestamibi 
distribution were displayed, both at rest and after exercise. 
Each polar map was normalized for peak myocardial activity 
and compared with the normal imits obtained in 50 gender- 
matched subjects with <5% probability of coronary artery 
disease: Pixels with tracer uptake falling >2.5 standard evia- 
tions (SD) below mean normal values were considered abnor- 
mal. The abnormal area on each short-axis lice was first 
multiplied by a correction factor (32) that corrects the spatial 
distortion and allows for differences in myocardial slice mass 
from apex to base. Corrected abnormal areas were then 
summed to obtain the total size of left ventricular defect, both 
at rest and after exercise, expressed as a percent of the left 
ventricular surface. Changes in the perfusion defect size from 
rest to exercise were considered significant when they ex- 
ceeded the 95% confidence limits of method variability. 
Echocardiography: data acquisition and analysis. All pa- 
tients underwent a complete rest echocardiographic study in 
multiple views (Hewlett-Packard 77020A) at both study 1 and 
study 2; the position of the patient and transducer was noted 
for use in serial studies. Our methods of data acquisition, 
image digitalization and the computerized system for the 
automatic detection and quantification of regional wall mo- 
tion, left ventricular function and remodeling have been pre- 
viously described (10,30,33). In brief, the three apical views 
(four- and two-chamber and apical ong-axis) were analyzed to 
assess left ventricular dimensions and function from three 
different planes and to explore six different ventricular walls 
from the base to the apex of the heart. The endocardial 
contour of each view was divided by the computer into 23 
segments of equal length, so that he entire ventricular wall was 
represented bya total of 69 segments. By comparison with our 
normal data base, the presence of abnormal wall motion was 
automatically detected when the fractional shortening area 
from end-diastole to end-systole of each segment was <2 SD of 
the mean values in normal subjects. The extent of wall motion 
abnormalities was then calculated as a percent of the total 
endocardial length. Global ventricular enlargement and re- 
gional dilation were also automatically identified when the 
total endocardial surface area and segmental areas at the 
end-diastolic frame exceeded 2 SD of the mean values in 
healthy subjects. 
Topographic measurements were also derived to provide 
further insight into the remodeling process. These included 
expansion index, regional dilation and regional shape distor- 
tion. The expansion index was computed as the ratio of the 
asynergy-containing endocardial segment length to that of the 
corresponding segments in normal subjects. The extent of 
regional dilation was calculated as a percent of endocardial 
length of dilated segments to the total endocardial length. 
Regional shape distortion of dilated segments and of both 
asynergic and nonasynergic segments was also computed and 
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expressed as the ratio of area difference between dilated 
asynergic or nonasynergic segments in the patient and corre- 
sponding segments in normal subjects to the corresponding 
endocardial length in the normal subjects. 
Left ventricular ejection fraction was calculated using the 
biplane area-length method. All measurements were derived 
in blinded manner by a single experienced operator (P.G.) 
from three consecutive cardiac cycles, and the mean values 
were considered for the analysis. Intraobserver variability 
values in endocardial contouring and in the evaluation of 
end-diastolic and end-systolic endocardial surface area by our 
quantitative analysis both in healthy subjects and in patients 
with myocardial infarction have been previously reported (33). 
Coronary angiography. According to the protocol design, 
cardiac atheterization was performed in the 6-month interval 
"between the initial and final studies. After intracoronary 
nitroglycerin administration, selective angiograms were ob- 
tained in at least wo projections for the right coronary artery 
and at least four for the left coronary artery. The presence of 
a significant (>50% coronary diameter reduction) stenosis was 
assessed using caliper measurements in two orthogonal pro- 
jections by one experienced observer (P.S.) who was unaware 
of other information. The Thrombolysis n Myocardial Infarc- 
tion (TIMI) flow grade of the infarct-related vessel and the 
presence of collateral circulation were also assessed. 
Statistical analysis. Results are reported as mean value _+ 
SD. Patients were grouped according to the presence and 
extent of reversible perfusion defect on exercise scintigraphy. 
Baseline characteristics between groups were compared using 
one-way analysis of variance for independent samples. When 
differences between groups were present, the Sheff6 test was 
used to determine which differed significantly. The Kruskal- 
Wallis test was used to compare TIMI grade scores and the 
chi-square test to determine the significance of differences in 
rates of occurrence. The echocardiographic data were analyzed 
comparing the initial (study 1) with the final study (study 2). 
Differences between groups and changes over time within each 
group, as well as any interaction (differing trends between 
groups), were assessed by multivariate repeated-measures 
analysis of variance combined with the Sheff6 test. Differences 
were considered significant at p < 0.05. 
Resu l ts  
Of the initial 96 patients who underwent rest and stress 
sestamibi imaging and echocardiography 5 weeks after infarc- 
tion, 1 died of sudden death during the 6-month period of the 
study; 4 others were withdrawn from the study because 
of clinical worsening or scintigraphic pattern and exten- 
sive coronary artery disease requiring coronary bypass urgery 
or coronary angioplasty. Thus, the remaining 91 medically 
treated patients underwent rest echocardiography 6 months 
later (study 2) and completed the serial protocol while in a 
clinically stable condition. 
Coronary anatomy. Coronary angiography, available in 72 
patients (79%), was performed on average 96 _+ 12 days from 
study 1. No clinical events or silent myocardial infarctions 
occurred before or after coronary angiography during the 
6-month period of the study. Significant stenoses involving one 
and two vessels were found in 47 (65.3%) and 19 (26.3%) 
patients, respectively. One patient (1.4%) had three-vessel 
disease, and no significant stenosis was documented in the 
remaining five patients (7%). The infarct-related vessel steno- 
sis affected the proximal eft anterior descending artery in 26 
patients (36%) and its middistal part in 46 (64%). A patent 
infarct-related vessel was found in 43 patients (60%), including 
41 with TIMI flow grade 3 and 2 with TIMI grade 2. Angio- 
graphically visible collateral vessels toward the infarct-related 
vessel were observed in 22 patients (30.5%). 
Exercise sestamibi imaging. Significant ECG changes (ST 
segment depression >_1 mm), chest pain and reversible 
(exercise-rest) perfusion defects were observed in 16 (18%), 6 
(7%) and 71 (78%) patients, respectively. On the basis of the 
presence and extent of reversible perfusion defect, patients 
were classified as having no exertional ischemia, as defined by 
no significant changes in the extent of the perfusion defect 
from rest to exercise (group 1, 20 patients [22%]); mild- 
moderate exertional ischemia, arbitrarily defined by an 
exercise-rest difference in the perfusion defect extent up to 
10% of the total eft ventricular surface (group 2, 45 patients 
[49%]) or severe exertional ischemia with >10% of the 
exercise-rest defect extent (group 3, 26 patients [29%]). 
Clinical and angiographic findings in the three groups are 
reported in Table 1. Peak serum creatine kinase levels and the 
proportion of patients who received thrombolytic therapy as 
well as those with a patent infarct-related vessel were compa- 
rable in the three groups. Although multivessel coronary 
disease and collateral vessels were more frequent in group 3 
than in groups 1 and 2, the differences were not statistically 
significant. Furthermore, there was no difference among the 
three groups in the medications received uring the 6-month 
period of the study. Ergometric results and exercise scinti- 
graphic data are summarized in Table 2. Exercise duration, 
peak rate-pressure product and the number of patients with 
ST segment depression during exercise were similar in the 
three groups. All patients howed sestamibi uptake defects at 
rest in the region supplied by the left anterior descending 
coronary artery, but no differences were found in the total 
extent of the rest defect among the three groups. Because the 
study patients were grouped on the basis of the presence and 
extent of reversible perfusion defect, exercise sestamibi defect 
size and reversible defect extent were greater in group 3 than 
in groups 1 and 2. 
Left ventricular function and topography from serial rest 
echocardiographic studies. At 5 weeks after infarction (study 
1), endocardial surface area, volumes, ejection fraction, per- 
cent wall motion abnormalities and topographic ndexes were 
similar in the three groups. After 6 months (study 2), all groups 
demonstrated a slight (p < 0.01) increase in ejection fraction 
with a decrease in percent wall motion abnormalities and 
expansion index. Although regional dilation and ventricular 
shape distortion did not change, aslight but significant increase 
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Table 1. Clinical and Angiographic Findings in Patients With No 
(group 1), Mild to Moderate (group 2) and Severe (group 3) 
Exertional Ischemia 
Group 1 Group 2 Group 3 
(n = 20) (n = 45) (n = 26) 
Age (yr) 51 + 7 50 + 7 49 +_ 7 
History 
Smoking 15 (75%) 33 (73%) 19 (73%) 
Hypertension 5 (25%) 11 (24%) 6 (23%) 
Diabetes 2 (10%) 4 (9%) 2 (8%) 
Acute phase of infarction 
Peak serum CK (IU/ml) 2,680 _+ 1,072 2,521 _+ 993 2,480 _+ 980 
Thrombolysis 15 (75%) 30 (67%) 19 (73%) 
Killip class I 18 (90%) 39 (87%) 23 (88%) 
Coronary angiography 19 (95%) 33 (73%) 20 (77%) 
No CAD 3 (16%) 2 (6%) 0 
Single LAD disease 13 (68%) 21 (64%) 13 (65%) 
Muttivessel disease 3 (16%) 10 (30%) 7 (35%) 
Infarct vessel 
TIMI flow grade 2.2 _+ 1.2 1.9 -+ 1.3 1.7 -+ 1.3 
Patency 12 (63%) 20 (61%) 11 (55%) 
Collateral vessels 4 (21%) 10 (33%) 8 (40%) 
Medications 
Beta-blockers 15 (75%) 34 (76%) 19 (73%) 
Nitrates 4 (20%) 10 (22%) 6 (23%) 
Calcium channel blockers 1 (5%) 4 (9%) 2 (8%) 
ACE inhibitors 4 (20%) 8 (18%) 5 (19%) 
Data presented are mean value -+ SD or number (%) of patients. ACE = 
angiotensin-converting e zyme; CAD = coronary artery disease; CK = creatine 
kinase; LAD = left anterior descending coronary artery; TIMI - Thrombolysis 
in Myocardial Infarction. 
in global ventricular size (endocardial surface area and end- 
diastolic volume) was observed at study 2 in all groups (Table 
3). 
As expected, patients with an ejection fraction _<40% had 
greater endocardial surface area and volumes, more extensive 
wall motion abnormalities with more pronounced regional 
dilation, infarct expansion and shape distortion at study 1 than 
those with an ejection fraction >40% (p < 0.0001). Moreover, 
patients with a low ejection fraction at the initial study showed 
further (p < 0.01) ventricular enlargement with an increase in 
regional dilation and ventricular shape distortion after 6 
months, involving both the asynergic and nonasynergic seg- 
ments (Table 4). However, these changes in both global 
ventricular size and topography were observed only in patients 
in groups 2 and 3 with a low ejection fraction. In contrast, 
endocardial surface area, volumes, expansion index, regional 
dilation and distortion did not change in group 1 patients with 
poor left ventricular function (Table 5). Finally, ventricular 
dimensions and topographic variables did not change (or 
showed a slight improvement) in patients in all groups with an 
ejection fraction >40% (Table 6). 
Discuss ion  
After acute myocardial infarction, ventricular dilation may 
play an important active role in the development of chronic 
heart failure (2,3,5,6,9), and left ventricular volume is the most 
powerful predictor of survival in patients with coronary artery 
disease (11). 
Determinants of progressive ventrieular dilation. Several 
factors and variables have been identified that predict an 
increase in left ventricular volume after myocardial infarction. 
These include infarct size and location, reperfusion, infarct 
healing, ventricular wall stress, different loading conditions, 
continued ischemia and medications (5-10,13-24). That the 
remodeling response after myocardial infarction may be atten- 
uated by reperfusion is supported by both experimental nd 
clinical data (13-18). In patients who have undergone throm- 
bolysis, other factors are also important in the remodeling 
response, including the level of blood flow after reperfusion, 
degree of residual coronary stenosis and occurrence of reoc- 
clusion (25-27). Recently, Gaudron et al. (9) further clarified 
the determinants of late unfavorable ft ventricular remodel- 
ing in patients receiving thrombolysis. In a study of 70 patients 
without clinical heart failure after a first myocardial infarction, 
cardiac catheterization and coronary angiography were per- 
formed at 3 to 5 weeks, and left ventricular volumes and 
ejection fraction were then studied serially over a 3-year period 
by radionuclide angiography. On multivariate analysis, predic- 
tors of progressive l ft ventricular dilation were myocardial 
infarct size, ejection fraction, anterior infarct location, stroke 
volume index and TIMI flow grade <2. Therefore, although 
several factors may influence and modify the remodeling 
Table 2. Ergometric Results at 5 Weeks After Infarction (study 1) in Patients With No (group 1), Mild to Moderate (group 2) and Severe 
(group 3) Exertional Ischemia 
Group 1 Group 2 Group 3 
(n - 20) (n = 45) (n = 26) 
Exercise duration (min) 
Rate-pressure product (mm Hg X beats/min X 103) 
Chest pain 
ST segment depression ->1 mm 
Rest sestamibi defect extent (%) 
Exercise sestamibi defect extent (%) 
Reversible sestamibi defect extent (exercise - rest defect) (%) 
11.6 _+ 1.6 11.6 -+ 1.7 11.8 ± 1.8 
24,144 + 4,663 25,261 _+ 4,294 23,463 + 3,897 
0 4 (9%) 2 (8%) 
3 (15%) 8 (18%) 5 (19%) 
27 -+ 18 33 -+ 14 27 -+ 14 
27 + 17 40 + 12" 44 + lOt~ 
1 _+ 0.5 6.2 _+ 2* 16 _+ 4t~ 
*p < 0.001, group 1 versus group 2. tP < 0.0001, group 1 versus group 3. Sp < 0.001 group 2 versus group 3. Data presented are mean value _+ SD or number 
(%) of patients. 
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Table 3. Left Ventricular Function and Topography at 5 Weeks 
(study 1) After Infarction and 6 Months Later (study 2) in Patients 
With No (group 1), Mild to Moderate (group 2) and Severe (group 
3) Exertional Ischemia 
Group 1 Group 2 Group 3 
(n = 20) (n = 45) (n = 26) 
Endocardial surface area 
(cm2/m 2)
Study 1 54 ± 9 54 _+ 9 53 ± 7* 
Study 2 55 ± 9 55 -+ 9 54 ± 9 
End-diastolic volume (ml/m 2) 
Study 1 64 ± 17 61 ± 15 61 ± 13" 
Study 2 65 ± 18 63 ± 19 63 ± 16 
End-systolic volume (ml/m 2) 
Study 1 35 ± 16 33 ± 16 30 _+ 13 
Study 2 35 ± 18 33 ± 18 29 _+ 16 
. Ejection fraction (%) 
Study 1 48 _+ 14 49 ± 14 52 ± 13' 
Study 2 49 ± 16 51 ± 15 56 _+ 12 
Wall motion abnormalities (%) 
Study 1 34 ± 18 33 _+ 15 29 ± 14 
Study 2 33 ± 21 30 ± 19 23 ± 18 
Expansion index 
Study 1 1.0 _+ 0.2 1.1 ± 0.1 1.1 ± 0.1" 
Study 2 0.9 ± 0.4 1.0 ± 0.3 0.9 ± 0.4 
Regional dilation (%) 
Study 1 24 ± 24 22 _+ 22 18 ± 20 
Study 2 24 ± 25 27 _+ 27 19 _+ 20 
Distortion of dilated segments 
Study 1 0.50 ± 0.36 0.41 ± 0.36 0.47 ± 0.30 
Study 2 0.48 ± 0.37 0.42 ± 0.34 0.48 ± 0.40 
*p < 0.01 within groups. Data presented are mean value ± SD. See text for 
further explanation. 
process, it appears that the extent and location of the damaged 
myocardial area are major determinants of left ventficular 
dilation and function after myocardial infarction. 
However, infarct size, left ventricular volume, ejection 
fraction and prognosis are closely related. Using a detailed 
quantitative echocardiographic analysis, we demonstrated in 
this study that patients with a low ejection fraction (_<40%) at 
the time of the initial study (5 weeks after infarction) had more 
significant ventricular dilation than those with preserved ven- 
tricular function, with more extensive functional infarct size 
and more pronounced shape distortion. These patients showed 
further ventficular enlargement after 6 months, which involved 
both the asynergic and normally contracting segments. Con- 
versely, ventricular cavity dimensions and topography did not 
change in patients with an ejection fraction >40% and normal 
ventricular volume at the initial study (Table 4). Thus, in 
accordance with previous observations, our data agree that 
patients with poor left ventricular function and early ventric- 
ular dilation, which often occur after a large anterior myocar- 
dial infarction, are prone to progressive ventricular enlarge- 
ment and dysfunction. 
Residual isehemia and remodeling. The effects of acute 
myocardial ischemia on both global and regional left ventric- 
ular function have been extensively demonstrated (28,29). 
Table 4, Left Ventricular Function and Topography at 5 Weeks 
(study 1) After Infarction and 6 Months Later (study 2) in Patients 
With Low or Preserved Ejection Fraction 
Ejection Fraction 
_<40% (n = 33) >40% (n = 58) 
Endocardial surface area (cmZ/m z)
Study 1 60 + 5 50 ± 6*t 
Study 2 63 ± 8 50 ± 7 
End-diastolic volume (ml/m 2) 
Study 1 74 ± 12 54 ± 10*t 
Study 2 80 ± 16 55 ± 12 
End-systolic volume (ml/m 2) 
Study 1 50 _+ 13 24 ± 9*t 
Study 2 52 + 17 23 ± 11 
Ejection fraction (%) 
Study 1 34 ± 6 56 ± 8':~ 
Study 2 35 ± 7 59 ± i0 
Wall motion abnormalities (%) 
Study 1 47 ± 7 24 ± 11'~ 
Study 2 45 ± 10 20 ± 15 
Expansion index 
Study 1 1.15 ± 0.08 1.06 ± 0.15*t 
Study 2 1.2 ± 0.1 0.9 ± 0.3 
Regional dilation (%) 
Study 1 43 -+ 16 11 ± 13*t 
Study 2 50 ± 22 10 + 15 
Distortion of dilated segments 
Study 1 0.74 _+ 0.13 0.45 _+ 0.31*t 
Study 2 0.79 ± 0.12 0.35 ± 0.30 
Distortion of asynergic segments 
Study 1 0.49 _+ 0.18 0.14 ± 0.2*t 
Study 2 0.56 ± 0.20 0.14 ± 0.1 
Distortion of nonasynergic segments 
Study 1 0.49 _+ 0.21 0.i ± 0.1*t 
Study 2 0.54 ± 0.30 0.09 ± 0.1 
*p < 0.001 between groups, tP < 0.01 interaction. :~p < 0.01 within groups. 
Data presented are mean value _+ SD. See text for further explanation. 
Ongoing ischemia fter myocardial infarction, either symptom- 
atic or asymptomatic, s associated with unfavorable short- and 
long-term prognoses, mainly because of an increased risk of 
successive coronary events (34,35). Severe and recurrent isch- 
emia may even induce a marked deterioration i ventricular 
function and symptoms of congestive heart failure in some 
patients (28). However, the prognostic value of exercise- 
induced myocardial ischemia is still uncertain (36-38), and no 
data are available on the possible role of residual exertional 
ischemia in progressive ventricular dilation after myocardial 
infarction. 
Present study. In the present study, because of the low 
sensitivity of exercise lectrocardiography in detecting myocar- 
dial ischemia, especially in patients with anterior infarct 
(39,40), the presence and extent of exertional ischemia were 
defined by quantitative analysis of reversible (exercise - rest) 
perfusion defects on stress cintigraphic maging performed 5 
weeks after the acute pisode. For analysis, patients were 
assigned to groups with no exercise-induced myocardial isch- 
emia or with mild-moderate or severe exertional ischemia. 
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Table 5. Left Ventricular Function and Topographic Variables at 
5 Weeks (study 1) After Infarction and 6 Months Later (study 2) 
by Study Group in Patients With Low Ejection Fraction 
Ejection Fraction _<40% 
Group 1 Group 2 Group 3 
(n = 7) (n = 17) (n = 9) 
Endocardial surface area 
(cm2/m e)
Study 1 63 ± 7 61 _+ 6 59 ± 6* 
Study 2 62 ± 8 63 -+ 7 63 ± 10 
End-diastolic volume (ml/m:) 
Study 1 78 ± 14 74 _+ 13 72 _+ 11' 
Study 2 78 -+ 5 80 ± 17 81 ± 19 
End-systolic volume (ml/m a) 
Study 1 59 ± 13 49 _+ 12 45 ± 8* 
Study 2 55 -+ 15 53 _+ 16 47 _+ 16 
Ejection fraction 
Study 1 32 + 6 35 ± 6 36 -+ 2 
Study 2 31 ± 8 35 ± 7 38 ± 7 
Wall motion abnormalities (%) 
Study 1 53 ± 5 46 + 7 47 +_ 4 
Study 2 53 + 10 46 ± 10 44 ± 9 
Expansion i dex 
Study 1 1.17 ± 0.08 1.18 ± 0.07 1.18 ± 0.10" 
Study 2 1.15 + 0.10 1.20 ± 0.09 1.23 ± 0.12 
Regional dilation (%) 
Study 1 52 ± 20 42 ± 16 38 ± 18" 
Study 2 47 _+ 28 52 _+ 22 46 ± 27 
Distortion of dilated segments 
Study 1 0.79 ± 0.14 0.74 + 0.14 0.75 + 0.13" 
Study 2 0.78 -+ 0.13 0.79 _+ 0.15 0.79 ± 0.20 
*p < 0.01 interaction. Data presented are mean value -+ SD. See text for 
further explanation. 
Table 6. Left Ventricular Function and Topographic Variables at 
5 Weeks (study 1) After infarction and 6 Months Later (study 2) 
by Study Group in Patients With Preserved Ejection Fraction 
Ejection Fraction >40% 
Group 1 Group 2 Group 3 
(n = 13) (n = 28) (n = 17) 
Endocardial surface area 
(cmS/m 2)
Study 1 51 -+ 6 50 ± 7 51 + 5 
Study 2 51 -+ 8 50 - 7 51 -+ 6 
End-diastolic volume (ml/m 2) 
Study I 58 ± 15 52 -+ 9 56 + 11 
Study 2 59 ± 16 53 ± 10 56 ± 12 
End-systolic volume (ml/m 2) 
Study 1 27 ± 10 23 -+ 8 24 ± 9 
Study 2 27 _+ 13 22 + 9 23 ± 10 
Ejection fraction 
Study 1 56 _+ 9 57 ± 10 58 ± 9* 
Study 2 57 ± 11 60 + 10 61 +_ 10 
Wall motion abnormalities (%) 
Study 1 25 ± 15 24 ± 13 23 ± 9* 
Study 2 24 -+ 19 20 ± 15 17 ± 15 
Expansion i dex 
Study 1 0.99 ± 0.3 1.07 _+ 0.1 1.06 _+ 0.08* 
Study 2 0.77 _+ 0.2 0.9 + 0.09 0.8 + 0.09 
Regional dilation (%) 
Study 1 12 + 14 10 + 15 11 ± 15 
Study 2 15 ± 17 11 ± 17 8 ± 12 
Distortion of dilated segments 
Study 1 0.50 -+ 0.35 0.41 ± 0.36 0.47 ± 0.3* 
Study 2 0.40 ± 0.33 0.35 ± 0.34 0.35 ± 0.4 
*p < 0.01 within groups. Data presented are mean value ± SD. See text for 
further explanation. 
The patient groups were well matched in terms of baseline 
clinical characteristics, initial ventricular volumes, extent of 
wall motion abnormalities and rest perfusion defects. Patients 
who received thrombolysis as well as those with single-vessel 
coronary disease and patency of infarct-related vessel were 
equally distributed in the three groups. Although multivessel 
coronary disease and collateral vessels were more frequent in 
patients with severe exertional ischemia, and the TIMI flow 
grade of the infarct vessel was greater in patients with no 
exercise-induced myocardial ischemia, the differences were not 
statistically significant. Finally, we did not find significant 
differences among the three groups in the remodeling response 
over the 6-month period of the study (Table 3). 
However, in patients with _<40% ejection fraction (who 
showed, as a whole, progressive ventricular dilation), a signif- 
icant increase in left ventricular volume was observed only in 
those with exercise-induced myocardial ischemia. Changes 
over time in both global ventricular size and topographic 
indexes of regional dilation and shape distortion were similar 
in patients with either mild-moderate or severe exertional 
ischemia. In contrast, patients with reduced ejection fraction 
and no exercise-induced myocardial ischemia who had compa- 
rable ventricular volumes on the initial study did not demon- 
strate further deterioration in ventricular cavity dimensions 
and shape distortion (Table 5). Thus, although the number of 
patients with a low ejection fraction in the present study is too 
limited to substantiate fully a definitive conclusion, our find- 
ings suggest that in patients with initial ventricular dilation and 
reduced ejection fraction after a large anterior myocardial 
infarction, exercise-induced myocardial ischemia from residual 
stenosis of the infarct-related vessel or disease in other coro- 
nary vessels may further contribute to progressive ventricular 
enlargement over time. In this case, intermittent ischemia, 
which may occur during daily activity in either the infarcted or 
noninfarcted regions, probably induces a more marked in- 
crease in ventricular wall stress, resulting in progressive ven- 
tricular dilation with further functional impairment and, even- 
tually, congestive heart failure (28). Conversely, in patients 
with a low ejection fraction and no exertional ischemia, the 
increase in ventricular wall stress is less pronounced, so that 
the initial ventricular dilation after a large infarction does not 
tend to be progressive. 
Finally, in patients with an ejection fraction >40% (in 
whom left ventricular size and topography were stable over 
time, with a slight improvement in ejection fraction), exercise- 
induced myocardial ischemia, either mild or severe, did not 
affect ventricutar remodeling and function after myocardial 
infarction (Table 6). In a recent study by Miller et al. (41) 
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severe xercise-induced myocardial ischemia failed to identify 
patients with normal eft ventricular function at increased risk 
of subsequent cardiac events. In line with this observation, our 
findings clearly demonstrate hat exertional ischemia does not 
even identify patients with preserved ventricular function at 
risk for progressive ventricular enlargement after infarction. 
Study limitations. In our study only few patients received 
drugs potentially interfering with the remodeling process 
(angiotensin-converting e zyme inhibitors, nitrates and other 
vasodilators). Most of the patients received beta-adrenergic 
blocking agents as a common policy of treatment in the 
postinfarction period, and they were equally distributed in the 
three groups. We studied a selected group of relatively oung 
male patients, a high proportion of whom had single-vessel 
coronary disease. Furthermore, patients with standard contra- 
• indications to exercise (spontaneous ischemia, exertional an- 
gina uncontrolled by medical therapy, clinical heart failure) 
were carefully screened out. Patients with a very low ejection 
fraction (<25%) were also excluded because of the possible 
clinical instability of such patients oon after the acute episode. 
Therefore, the results of this study may not be applicable to all 
postinfarction patients but only to those without clinical 
complications. 
Clinical implications. The present study indicates that 
patients with ventricular dilation and poor left ventricular 
function soon after a large anterior myocardial infarction are 
subject o progressive ventricular enlargement when exercise- 
induced myocardial ischemia is documented. Therefore, in our 
opinion, these patients hould be thoroughly evaluated for the 
presence of exertional ischemia. In this context, because of the 
low sensitivity of exercise lectrocardiography, cardiac imaging 
techniques should be recommended. Bycontrast, in postinfarc- 
tion patients with preserved ventricular volume and function, 
exertional ischemia does not identify patients at risk for 
progressive ventricular dilation. 
Larger clinical trials are required to confirm our results and 
to verify whether a more intensive anti-ischemic therapy or 
coronary revascularization could prevent late unfavorable re- 
modeling in patients with left ventricular dilation and dysfunc- 
tion after myocardial infarction. 
We are grateful to Rosemary Allpress, MA for English language assistance in the 
preparation of the manuscript. 
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